1. Chemotherapy does not impair parenchymal sparing surgery to treat colorectal liver metastases. (February 2017) Authors: Evrard, S.; Desjardin, M.; Brouste, V.; Bonhomme, B.; Fonck, M.; Becouarn, Y.; Bechade, D.; Desolneux, G. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials. (July 2018) Authors: Adenis, A.; Alessio, A.; Aouakli, A.; Azzedine, A.; Bedjaoui, A.; Bidault, A.; Blanchi, A.; Botton, A.; Cadier-Lagnes, A.; Fatisse, A.; Gagnaire, A.; Gilbert, A.; Gueye, A.; Hollebecque, A.; Lemaire, A.; Mahamat, A.; Marre, A.; Patenotte, A.; Rotenberg, A.; Roussel, A. Journal: European journal of cancer Issue: Volume 98(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab. (18th April 2016) Authors: Cousin, S.; Toulmonde, M.; Kind, M.; Cazeau, A.-L.; Bechade, D.; Coindre, J.-M.; Italiano, A. Journal: Annals of oncology Issue: Volume 27:Number 6(2016:Jun.) Page Start: 1178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗